Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease
NCT02062021 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200000
Last updated 2015-04-21
Summary
Autoimmune diseases are diseases in which inappropriate immune responses that have the capability of harming host cells play an important role. Evidence suggests that the presence of certain autoimmune diseases such as rheumatoid arthritis or systematic lupus erythematosus increase the risk of cardiovascular disease (CVD). However, this evidence is inconsistent for autoimmune disorders and no systematic approach has been previously used to study the relationship between a range of common autoimmune disorders and specific forms of cardiovascular diseases such as myocardial infarction, intracerebral and subarachnoid haemorrhage, or venous thrombosis.
The investigators will use linked electronic health records to investigate whether commonly diagnosed autoimmune disorders are associated with increased risk of CVD development and whether effects differ in men and women and change with age.
Conditions
- Myocardial Infarction
- Ischemic Stroke
- Stroke
- Subarachnoid Haemorrhage
- Venous Thrombosis
- Transient Ischemic Attack
- Stable Angina Pectoris
- Unstable Angina
- Heart Failure
- Peripheral Arterial Disease
- Abdominal Aortic Aneurysm
Interventions
- OTHER
-
No intervention
Sponsors & Collaborators
-
Wellcome Trust
collaborator OTHER -
National Institute for Health Research, United Kingdom
collaborator OTHER_GOV -
University College, London
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2014-12-31
- Completion
- 2015-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
NCT00610805 ·Status: WITHDRAWN ·Phase: NA
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
NCT02890134 ·Status: COMPLETED
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
NCT02890147 ·Status: COMPLETED
-
Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease
NCT00188188 ·Status: UNKNOWN ·Phase: PHASE4
-
Lupus Atherosclerosis Prevention Study
NCT00120887 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe
NCT04397237 ·Status: UNKNOWN
-
Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases
NCT06169865 ·Status: RECRUITING
-
Cardiac Imaging in Systemic Disorders: the ORACLES Registry
NCT07134166 ·Status: NOT_YET_RECRUITING
-
Lupus Cohort--Thrombotic Events and Coronary Artery Disease
NCT00005436 ·Status: COMPLETED
-
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)
NCT00739050 ·Status: TERMINATED ·Phase: PHASE4
-
A Trial of Rosuvastatin in Systemic Lupus Erythematosus
NCT01170585 ·Status: COMPLETED ·Phase: PHASE2
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus
NCT04580108 ·Status: COMPLETED
-
Occupational and Environmental Causes of Autoimmune Diseases
NCT07000903 ·Status: COMPLETED ·Phase: NA
-
Systemic Lupus Erythematous and Heart Conduction Disorders
NCT02162992 ·Status: COMPLETED
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders
NCT07037732 ·Status: RECRUITING
-
Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis
NCT03526042 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
NCT06647069 ·Status: RECRUITING ·Phase: PHASE1
-
Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB
NCT06594861 ·Status: RECRUITING
-
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
NCT05383339 ·Status: RECRUITING
-
Insulin Resistance and Atherosclerosis in Women With Lupus
NCT00544102 ·Status: COMPLETED
-
Identifying New Therapeutic Targets for Lupus Treatment
NCT03921398 ·Status: COMPLETED
-
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
NCT03941184 ·Status: COMPLETED
-
This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLE
NCT06698900 ·Status: COMPLETED